OBJECTIVE To summarize the available evidence on the issues in health economics related
to oral anticoagulation for stroke prevention in atrial fibrillation (AF) in the US. DATA …

Introduction: Atrial fibrillation (AF) increases the risk of ischemic stroke 5‐fold and may not
only be responsible for as many as 15% of all strokes that occur but also for larger and more …

Objectives To conduct a systematic review of economic models of newer anticoagulants for
stroke prevention in atrial fibrillation (SPAF). Methods We searched Medline, Embase …

Objective To conduct a systematic review of economic models of newer anticoagulants for
stroke prevention in atrial fibrillation (SPAF). Patients and Methods We searched Medline …

Atrial fibrillation (AF) is predictive of higher costs for stroke care, in part due to the influence
of AF on stroke severity. Costs associated with severe strokes, which are more likely in …

Background and Purpose—The objective of the study is to compare the cost-effectiveness of
oral anticoagulants among atrial fibrillation patients at an increased stroke risk. Methods—A …

Background and Purpose—Stroke outcomes in patients with atrial fibrillation (AF) tend to be
worse than those in patients without AF. The objective of this study was to evaluate whether …

Atrial fibrillation (AF) is a common arrhythmia that significantly increases the risk of stroke by
the formation and embolism of left-atrial appendage thrombi. This risk can be substantially …

BACKGROUND AND PURPOSE: Previous cost-effectiveness analyses analyzed warfarin
for stroke prevention in randomized trial settings. Given the complexities of warfarin …

Objectives Several studies have evaluated the economic evaluation of a group of
medications known as novel oral anticoagulant drugs (NOACs) in recent years. The aim of …